In light of the discussion above concerning the compensatory role of OPG with respect to RANKL, it is implied that blocking the RANKL-RANK interaction with OPG might lead to a novel tool in the prevention and treatment of human metastatic NSCLC. Here, TNFRSF11A is linked to non-small cell lung carcinoma.